Systemic onset juvenile idiopathic arthritis
Item
so-jia (edmonton's revision of durban's consensus conference criteria)
boolean
C1384600 (UMLS CUI [1])
Age
Item
age: at least 2 years and less than 20 years at treatment initiation
boolean
C0001779 (UMLS CUI [1])
disease length
Item
disease duration of at least 6 months
boolean
C0872146 (UMLS CUI [1])
Adrenal Cortex Hormones | Therapeutic procedure failed | Adrenal Cortex Hormones U/day Patient need for | Body Weight
Item
failure of corticosteroid treatment or requirement for corticosteroid treatment at a daily dose equal to or over 0.3 mg/kg (10 mg in patients whose weight is over 34 kg)
boolean
C0001617 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0231175 (UMLS CUI [2,2])
C0001617 (UMLS CUI [3,1])
C0456683 (UMLS CUI [3,2])
C0686904 (UMLS CUI [3,3])
C0005910 (UMLS CUI [4])
Systemic symptoms Severe | Arthritis | Physician Global Assessment of Disease Activity | Disease Effect Overall Well Being Assessment | functional disability | Health status of children Assessment Questionnaire | Arthritis Joints Quantity | Limited range of motion in joints Quantity | Joint Damage Permanent | Ankylosis | Erythrocyte sedimentation rate measurement
Item
active and severe systemic symptoms and/or arthritis as assessed by an experienced pediatric rheumatologists, with at least 3 of the following criteria when assessing giannini's core-set items: 1) physician global assessment of disease activity of at least 20/100; 2) parent/patient assessment of disease effect on overall well-being of at least 20/100; 3) functional disability with a children health assessment questionnaire (chaq, ref [9]) score equal to or higher than 0.375/3; 4) 2 joints or more with active arthritis 5) 2 joints or more with non-irreversible limited range of motion (irreversible limited range of motion will be defined by radiological evidence of irreversible joint damage and ankylosis) 6) erythrocyte sedimentation rate (esr) equal to or higher than 20.
boolean
C2039684 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0003864 (UMLS CUI [2])
C4050369 (UMLS CUI [3])
C0012634 (UMLS CUI [4,1])
C1280500 (UMLS CUI [4,2])
C3813622 (UMLS CUI [4,3])
C1516048 (UMLS CUI [4,4])
C0872173 (UMLS CUI [5])
C1822480 (UMLS CUI [6,1])
C1516048 (UMLS CUI [6,2])
C0034394 (UMLS CUI [6,3])
C0003864 (UMLS CUI [7,1])
C0022417 (UMLS CUI [7,2])
C1265611 (UMLS CUI [7,3])
C3152018 (UMLS CUI [8,1])
C1265611 (UMLS CUI [8,2])
C0022417 (UMLS CUI [9,1])
C1883709 (UMLS CUI [9,2])
C0205355 (UMLS CUI [9,3])
C0003090 (UMLS CUI [10])
C1176468 (UMLS CUI [11])
Fever Disease Related Absence | Raised C-reactive protein | ESR raised
Item
in the absence of disease-related fever, either crp or first hour esr or both have to be over the upper limit of normal values so that treatment effect on the systemic part of the disease can be objectively evaluated.
boolean
C0015967 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
C1833181 (UMLS CUI [2])
C0151632 (UMLS CUI [3])
Polyarthritis | Inflammation joints Quantity | Limitation of motion
Item
patients with polyarthritis (at least 5 joints with inflammation and/or limitation of motion) will be eligible for this study only if at least 50% of the affected joints do not present radiological evidence of irreversible damage.
boolean
C0162323 (UMLS CUI [1])
C0574941 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0518456 (UMLS CUI [3])
Informed Consent parent | Informed Consent Patient Representative | Informed Consent
Item
informed consent signed by the parents or the person legally responsible for the patient if the patient is less than 18, and by the patient if old enough
boolean
C0021430 (UMLS CUI [1,1])
C0030551 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2,1])
C0030701 (UMLS CUI [2,2])
C0021430 (UMLS CUI [3])
Childbearing Potential Contraceptive methods | Childbearing Potential Sexual Abstinence
Item
teenager girls or young women with childbearing potential must use a contraceptive method (including abstinence
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0036899 (UMLS CUI [2,2])
Tuberculin test negative | Tuberculin test positive Immunization Related | Tuberculin test positive Intensity Normal
Item
tuberculin test performed before day 1 and must either be negative or positivity must be related to previous immunization and of normal intensity according to the investigator's judgment
boolean
C0853313 (UMLS CUI [1])
C0032739 (UMLS CUI [2,1])
C0020971 (UMLS CUI [2,2])
C0439849 (UMLS CUI [2,3])
C0032739 (UMLS CUI [3,1])
C0522510 (UMLS CUI [3,2])
C0205307 (UMLS CUI [3,3])
anakinra
Item
previous treatment with il-1ra
boolean
C0245109 (UMLS CUI [1])
Intra-Articular Injections | Non-Steroidal Anti-Inflammatory Agents Dose Changed | Adrenal Cortex Hormones Dose Changed
Item
intra-articular injection or change in the doses of non-steroidal anti-inflammatory drugs and corticosteroids in the 4 weeks preceding the initiation of anakinra treatment
boolean
C0021488 (UMLS CUI [1])
C0003211 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0392747 (UMLS CUI [2,3])
C0001617 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0392747 (UMLS CUI [3,3])
Immunosuppressive Agents | Pharmaceutical Preparations Disease Modification
Item
treatment with another immunosuppressive or disease-modifying drugs that could not be stopped before inclusion (for a duration depending on the drug pharmacokinetic properties)
boolean
C0021081 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C0392747 (UMLS CUI [2,3])
Medical contraindication anakinra | Medical contraindication Communicable Diseases | Hypersensitivity Escherichia coli Derivative
Item
contra-indication to the use of anakinra including ongoing active infection or allergy to e coli's derivate or other components of the drug
boolean
C1301624 (UMLS CUI [1,1])
C0245109 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C0009450 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0014834 (UMLS CUI [3,2])
C1527240 (UMLS CUI [3,3])
Malignant Neoplasms | Heart failure
Item
previous history of malignancy or heart insufficiency
boolean
C0006826 (UMLS CUI [1])
C0018801 (UMLS CUI [2])
Asthma | Pneumonology Assessment Patient need for
Item
patients with asthma require to be previously assessed by a pneumonologist
boolean
C0004096 (UMLS CUI [1])
C0034060 (UMLS CUI [2,1])
C1516048 (UMLS CUI [2,2])
C0686904 (UMLS CUI [2,3])
Therapeutic Intervention Patient need for | Operative Surgical Procedures | Intra-Articular Injections | Live Vaccine Administration
Item
obvious need of therapeutic intervention before study completion such as surgery, intra-articular injection, life vaccine administration
boolean
C0808232 (UMLS CUI [1,1])
C0686904 (UMLS CUI [1,2])
C0543467 (UMLS CUI [2])
C0021488 (UMLS CUI [3])
C0042211 (UMLS CUI [4,1])
C1533734 (UMLS CUI [4,2])
White Blood Cell Count procedure | Neutrophil count | Platelet Count measurement | Serum creatinine raised | Alanine aminotransferase increased | Aspartate aminotransferase increased | Elevated total bilirubin
Item
any of the following: leucocyte counts < 3.6 x 10e9/l, polymorphonuclear neutrophil counts < 1.5 x 10e9/l, platelets < 150 000/mm3, serum creatinin > 1.5 the upper limit of normal range for age, serum alanine and aspartate transaminases > 2 times the upper limit of the normal range, serum bilirubin > 2 times the upper limit of the normal range
boolean
C0023508 (UMLS CUI [1])
C0200633 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0700225 (UMLS CUI [4])
C0151905 (UMLS CUI [5])
C0151904 (UMLS CUI [6])
C0741494 (UMLS CUI [7])